Ingrezza Sprinkle Capsules Received FDA Approval for Tardive Dyskinesia in Adults
The new formulation was approved to help patients with tardive dyskinesia who have trouble swallowing.
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new formulation was approved to help patients with tardive dyskinesia who have trouble swallowing.
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License...
LONDON, April 29, 2024 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Journey Clinical, a leading...
/PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and...
Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical ...